BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34582541)

  • 1. Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer.
    Peng J; Wang R; Sun W; Huang M; Wang R; Li Y; Wang P; Sun G; Xie S
    Biomater Sci; 2021 Sep; 9(19):6528-6541. PubMed ID: 34582541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
    Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
    Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.
    Lv Q; Hu JX; Li YJ; Xie N; Song DD; Zhao W; Yan YF; Li BS; Wang PY; Xie SY
    Cancer Biol Ther; 2017 Mar; 18(3):142-151. PubMed ID: 28106481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D; Feng M; Ma X; Tao K; Wang G
    Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin.
    Chen W; Zhou Y; Zhi X; Ma T; Liu H; Chen BW; Zheng X; Xie S; Zhao B; Feng X; Dang X; Liang T
    Biomaterials; 2019 Feb; 192():590-600. PubMed ID: 30553134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
    Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
    Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3.
    Lu Y; Wu D; Wang J; Li Y; Chai X; Kang Q
    Biochem Biophys Res Commun; 2016 May; 473(4):1315-1320. PubMed ID: 27086852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p100 functions as a metastasis activator and is targeted by tumor suppressing microRNA-320a in lung cancer.
    Xing A; Pan L; Gao J
    Thorac Cancer; 2018 Jan; 9(1):152-158. PubMed ID: 29159900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression.
    Zhang G; Jiang G; Wang C; Zhong K; Zhang J; Xue Q; Li X; Jin H; Li B
    Oncotarget; 2016 Aug; 7(31):49470-49480. PubMed ID: 27304056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of miR-320a in lung cancer: a comprehensive review.
    Mohanta A; Kumar RR; Singh RK; Mandal S; Yadav R; Khatkar R; Sharma U; Uttam V; Rana MK; Rana AP; Jain A
    Biomark Med; 2023 Sep; 17(18):767-781. PubMed ID: 38095986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-320a/SP1 negative reciprocal interaction contributes to cell growth and invasion in colorectal cancer.
    Zhang W; Yang H; Wang Z; Wu Y; Wang J; Duan G; Guo Q; Zhang Y
    Cancer Cell Int; 2021 Mar; 21(1):175. PubMed ID: 33731131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.
    Sun L; Liu B; Lin Z; Yao Y; Chen Y; Li Y; Chen J; Yu D; Tang Z; Wang B; Zeng S; Fan S; Wang Y; Li Y; Song E; Li J
    Mol Cancer; 2015 Apr; 14():96. PubMed ID: 25924850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.
    Wang J; Shi C; Wang J; Cao L; Zhong L; Wang D
    Oncol Lett; 2017 May; 13(5):3247-3252. PubMed ID: 28521431
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Tan Z; Jia J; Jiang Y
    Biosci Rep; 2018 May; 38(3):. PubMed ID: 29654167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-catenin.
    Sun JY; Huang Y; Li JP; Zhang X; Wang L; Meng YL; Yan B; Bian YQ; Zhao J; Wang WZ; Yang AG; Zhang R
    Biochem Biophys Res Commun; 2012 Apr; 420(4):787-92. PubMed ID: 22459450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-326/Sp1/KLF3: A novel regulatory axis in lung cancer progression.
    Wang R; Xu J; Xu J; Zhu W; Qiu T; Li J; Zhang M; Wang Q; Xu T; Guo R; Lu K; Yin Y; Gu Y; Zhu L; Huang P; Liu P; Liu L; De W; Shu Y
    Cell Prolif; 2019 Mar; 52(2):e12551. PubMed ID: 30485570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-320a contributes to atherogenesis by augmenting multiple risk factors and down-regulating SRF.
    Chen C; Wang Y; Yang S; Li H; Zhao G; Wang F; Yang L; Wang DW
    J Cell Mol Med; 2015 May; 19(5):970-85. PubMed ID: 25728840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
    Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
    Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element-binding protein 1.
    Wang Y; Yang J; Chen P; Song Y; An W; Zhang H; Butegeleqi B; Yan J
    Cancer Med; 2020 Apr; 9(8):2833-2845. PubMed ID: 32064777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.